EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrative omics analysis identifies biomarkers of septic cardiomyopathy

Kexin Cai, Yuqing Luo, Hongyin Chen, Yanfang Dong, Yunyun Su, Chen Lin, Chuanqi Cai, Yikbin Shi, Siming Lin, Guili Lian, Zhihong Lin, Shaodan Feng iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0310412 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Kexin Cai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, The First Affiliated Hospital of Fujian Medical University, Fujian, Fuzhou, China. Hauptthemen laut MEDLINE: Cardiomyopathies, Biomarkers, Sepsis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Provincial Maternity and Children’s Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Septic Cardiomyopathy (SCM) is a syndrome of acute cardiac dysfunction in septic patients, unrelated to cardiac ischemia. Multiomics studies including transcriptomics and proteomics have provided new insights into the mechanisms of SCM. In here, a rat model of SCM was established by intraperitoneal injection of lipopolysaccharide (LPS). Biomarkers of SCM were characterized via a multi-omics analysis. The differentially expressed (DE) mRNAs predominantly appeared in pathways linked to the immune response, inflammatory response, and the complement and coagulation cascades, while DE proteins were mainly enriched in pathways associated with the complement and coagulation cascades. On this basis, the integrated analysis was performed between transcriptome and proteome. The potential biomarkers were further verified by RT-qPCR and WB. The current proteotranscriptomic research has furnished a valuable dataset and fresh perspectives that will enhance our comprehension of the development of SCM. This, in turn, is expected to expedite the formulation of novel approaches for the prevention and management of SCM in patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomyopathiesBiomarkersSepsisAnimalsRatsMaleProteomicsTranscriptomeLipopolysaccharidesDisease Models, AnimalGene Expression ProfilingRats, Sprague-DawleyProteomeMultiomics

Substanzen

BiomarkersLipopolysaccharidesProteome

Autor:innen und Institutionen

  • Department of Emergency, The First Affiliated Hospital of Fujian Medical University, Fujian, Fuzhou, China.
  • Fujian Hypertension Research Institute, The First Affiliated Hospital of Fujian Medical University, Fujian, Fuzhou, China.
  • Department of Emergency, The Third Affiliated People's Hospital, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
  • Department of Emergency, National Regional Medical Center, Binhai Campus of The First Affiliated Hospital, Fujian Medical University, Fujian, Fuzhou, China.

ORCID-Profile: Shaodan Feng

Förderung

  • Fujian Provincial Maternity and Children’s Hospital

Zitieren

APA

Cai, K., Luo, Y., Chen, H., Dong, Y., Su, Y., Lin, C., Cai, C., Shi, Y., Lin, S., Lian, G., Lin, Z., & Feng, S. (2024). Integrative omics analysis identifies biomarkers of septic cardiomyopathy. PLOS ONE. https://doi.org/10.1371/journal.pone.0310412

Vancouver

Cai K, Luo Y, Chen H, Dong Y, Su Y, Lin C, et al. Integrative omics analysis identifies biomarkers of septic cardiomyopathy. PLOS ONE. 2024. doi:10.1371/journal.pone.0310412

BibTeX
@article{Cai2024,
  author = {Cai, Kexin and Luo, Yuqing and Chen, Hongyin and Dong, Yanfang and Su, Yunyun and Lin, Chen and Cai, Chuanqi and Shi, Yikbin and Lin, Siming and Lian, Guili and Lin, Zhihong and Feng, Shaodan},
  title = {Integrative omics analysis identifies biomarkers of septic cardiomyopathy},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0310412}
}
Kostenlos starten →